000 | 01940 a2200553 4500 | ||
---|---|---|---|
005 | 20250516141923.0 | ||
264 | 0 | _c20131024 | |
008 | 201310s 0 0 eng d | ||
022 | _a1399-6576 | ||
024 | 7 |
_a10.1111/aas.12095 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAxelsson, B | |
245 | 0 | 0 |
_aMilrinone and levosimendan during porcine myocardial ischemia -- no effects on calcium overload and metabolism. _h[electronic resource] |
260 |
_bActa anaesthesiologica Scandinavica _cJul 2013 |
||
300 |
_a719-28 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCalcium _xmetabolism |
650 | 0 | 4 |
_aCalcium Radioisotopes _xpharmacokinetics |
650 | 0 | 4 |
_aCardiotonic Agents _xadministration & dosage |
650 | 0 | 4 | _aDrug Evaluation, Preclinical |
650 | 0 | 4 |
_aEnergy Metabolism _xdrug effects |
650 | 0 | 4 |
_aGlucose _xadministration & dosage |
650 | 0 | 4 |
_aGlycolysis _xdrug effects |
650 | 0 | 4 | _aHeart Ventricles |
650 | 0 | 4 |
_aHemodynamics _xdrug effects |
650 | 0 | 4 |
_aHydrazones _xadministration & dosage |
650 | 0 | 4 | _aInfusions, Intravenous |
650 | 0 | 4 |
_aIon Transport _xdrug effects |
650 | 0 | 4 | _aMicrodialysis |
650 | 0 | 4 |
_aMilrinone _xadministration & dosage |
650 | 0 | 4 |
_aMyocardial Ischemia _xdrug therapy |
650 | 0 | 4 |
_aMyocytes, Cardiac _xdrug effects |
650 | 0 | 4 |
_aOxygen Consumption _xdrug effects |
650 | 0 | 4 | _aPremedication |
650 | 0 | 4 |
_aPyridazines _xadministration & dosage |
650 | 0 | 4 | _aRandom Allocation |
650 | 0 | 4 | _aSimendan |
650 | 0 | 4 | _aSus scrofa |
650 | 0 | 4 | _aSwine |
700 | 1 | _aJohansson, G | |
700 | 1 | _aAbrahamsson, P | |
700 | 1 | _aGupta, A | |
700 | 1 | _aTydén, H | |
700 | 1 | _aWouters, P | |
700 | 1 | _aHaney, M | |
773 | 0 |
_tActa anaesthesiologica Scandinavica _gvol. 57 _gno. 6 _gp. 719-28 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/aas.12095 _zAvailable from publisher's website |
999 |
_c22603443 _d22603443 |